Evogen's Cognizance Biomarkers Presents Data Showing Its Proteomic Biomarkers Have the Potential to Monitor Seizure Burden to Aid in Epilepsy Patient Management

Source :: Pharma Business Week. June 10, 2019, 40
Publication Year :: 2019
Abstract: 2019 JUN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Cognizance Biomarkers, LLC, a wholly-owned subsidiary of Evogen, Inc., a leader in proteomic and [...]

Subjects :: Management
Diagnosis
Company business management
Epilepsy -- Diagnosis
Medical research
Seizures (Medicine) -- Diagnosis
Biological markers
Physicians
Conferences and conventions
Editors
Genetic testing

Tools